Oliver Kaltenbrunner
Principal Scientist at Amgen, Inc.
|
|
Costing Issues in the Production of Biopharmaceuticals
February 1, 2004
By:
Anurag S. Rathore, PhD
,
Peter Latham
,
Oliver Kaltenbrunner
,
John Curling
,
Howard Levine
Operational planning and early cost analyses are key to generating optimal, robust, and economical commercial processes.
|
|